Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
117,689,775
-
Share change
-
+14,831,066
-
Total reported value
-
$2,058,545,943
-
Put/Call ratio
-
149%
-
Price per share
-
$17.49
-
Number of holders
-
203
-
Value change
-
+$247,622,200
-
Number of buys
-
102
-
Number of sells
-
122
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2025
As of 31 Dec 2025,
Summit Therapeutics Inc. - COM (SMMT) was held by
203 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
117,689,775 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, Polymer Capital Management (HK) LTD, and Pictet Asset Management Holding SA.
This page lists
203
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.